Results 21 to 30 of about 139,802 (315)

Infections Caused by Nontuberculous Mycobacteria in Recipients of Hematopoietic Stem Cell Transplantation

open access: yesFrontiers in Oncology, 2014
Nontuberculous mycobacteria (NTM) are acid-fast bacteria that are ubiquitous in the environment and can colonize soil, dust particles, water sources and food supplies.
Khalid Ahmed Al-Anazi   +2 more
doaj   +1 more source

Mycobacterium marinum lymphocutaneous infection [PDF]

open access: yesDermatology Online Journal, 2019
Mycobacterium marinum is a nontuberculous mycobacteria with worldwide distribution that lives in fresh or salt water and is responsible for infections in fish, and sometimes in humans. Human disease consists mainly of cutaneous nodules, but deep structure involvement may also occur. Diagnosis of M.
Bouceiro-Mendes, R   +8 more
openaire   +4 more sources

Mycobacterium chubuense hand infection

open access: yesIDCases, 2020
Mycobacterium chubuense is a scotochromogenic rapidly growing mycobacterium (RGM), a nontuberculous mycobacterium (NTM)that was first characterized in 1981. This case report describes a rare case of M. chubuense infection in the right hand of a 53-year-old man who lived in the coastal areas of Zhejiang province, China.
Jian Ruan, Xue-Yuan Li, Hong Chen
openaire   +3 more sources

Mycobacterium interjectumLung Infection [PDF]

open access: yesCase Reports in Pulmonology, 2013
A 62-year-old male presented with productive cough, weight loss, and night sweats. CXR revealed a right upper lobe cavitary lesion. Evaluation was negative forMycobacterium tuberculosis, and sputum revealedMycobacterium avium intracellulare(MAI).
M. C. Mirant-Borde   +2 more
openaire   +3 more sources

Mycobacterium szulgai cavitary lung disease progression over a three year period – A case report

open access: yesIDCases, 2022
Mycobacterium szulgai is a slow growing non-tuberculous mycobacterium associated with rare but severe infections. It most commonly presents as pulmonary disease in people with underlying structural lung disease.
Michael C. Croix, Sonal S. Munsiff
doaj   +1 more source

Mycobacterium riyadhense as the opportunistic infection that lead to HIV diagnosis: A report of 2 cases and literature review

open access: yesJournal of Infection and Public Health, 2019
Human immunodeficiency virus (HIV) infection usually presents with a wide range of manifestations. Although HIV patients are prone to pulmonary infections by opportunistic pathogens in the late stage of AIDS, manifesting the disease with pulmonary ...
Thamer H. Alenazi   +5 more
doaj   +1 more source

Tongue Tuberculosis as a Complication of Pott’s Disease in a Patient on Systemic Steroid Therapy without Pulmonary Tuberculosis

open access: yesMedicina
A 78-year-old man with a previous diagnosis of rheumatoid arthritis on prolonged treatment with corticosteroids presented with intense and progressive pain at the cervical level that prevented him from resting his head and walking, in addition to an ...
Samuel Sevilla-Fuentes   +5 more
doaj   +1 more source

Skin and soft tissue infection by Mycobacterium intracellulare in an immunocompetent patient

open access: yesIDCases, 2020
Nontuberculous mycobacteria (NTM) infections still represent a large group of insidious diseases hard to deal with. Traditionally, immunocompromised patients suffer from NTM infections, especially with respiratory involvement or disseminated diseases due
Alessio Pampaloni   +9 more
doaj   +1 more source

Molecular identification and typing of Mycobacterium massiliense isolated from postsurgical infections in Brazil

open access: yesBrazilian Journal of Infectious Diseases
OBJECTIVE: One hundred thirty-one cases of postsurgical infections were reported in Southern Region of Brazil between August 2007 and January 2008.
Fernanda Monego   +9 more
doaj   +1 more source

Tuberculosis and atypical mycobacterial infections in ruxolitinib-treated patients with primary or secondary myelofibrosis or polycythemia vera

open access: yesInternational Journal of Infectious Diseases, 2019
Ruxolitinib is a JAK-1/JAK-2 inhibitor indicated for the treatment of polycythemia vera and primary or secondary myelofibrosis. Only one patient (0.2%) was diagnosed with tuberculosis among the 485 patients receiving ruxolitinib in the four pivotal ...
Sylvain Lescuyer   +9 more
doaj   +1 more source

Home - About - Disclaimer - Privacy